When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New drug's potentially fatal side effects obscured by ... - AOL

   www.aol.com/news/drugs-potentially-fatal-side...

   A registered nurse demonstrates how to prepare an IV infusion of Leqembi, a drug for Alzheimer's disease, at a UCLA clinic in January. ... be given to the drug's potential side effects to better ...

3. How a new FDA-approved drug can — and can’t — help people ...

   www.aol.com/fda-approved-drug-t-help-121600044.html

   These side effects happen to about 1 in 5 patients who take the drug, notes Dr. Trinh. The better news: In most patients, those side effects haven’t been serious, or even noticeable sometimes.

4. Donanemab - Wikipedia

   en.wikipedia.org/wiki/Donanemab

   The US Food and Drug Administration (FDA) label for donanemab contains a boxed warning about amyloid-related imaging abnormalities. [1]Side effects may include infusion-related reactions, with symptoms such as flu-like symptoms, nausea, vomiting and changes in blood pressure, and hypersensitivity reactions, including anaphylaxis (severe, life-threatening allergic reaction) and angioedema ...

5. Biperiden - Wikipedia

   en.wikipedia.org/wiki/Biperiden

   Biperiden may lower the seizure-threshold. Some instances of dementia have been noted to correlate with chronic administration of anticholinergic medications such as biperiden for Parkinson's disease. [13] Peripheral side effects : Blurred vision, dry mouth, impaired sweating, abdominal discomfort, and obstipation are frequent.

6. Common drugs like ibuprofen could be associated with ... - AOL

   www.aol.com/common-drugs-ibuprofen-could...

   Repurposing current drugs to tackle dementia is an ‘urgent priority’, academics say, but other experts warn more work is needed before they can be used to help treat the disease

7. Injection site reaction - Wikipedia

   en.wikipedia.org/wiki/Injection_site_reaction

   For many biologics (e.g., monoclonal antibodies), injection site reactions are the most common adverse effect of the drug, and have been reported to have an incidence rate of 0.5–40%. [2] In trials of subcutaneous administration of oligonucleotides, between 22 and 100% of subjects developed reactions depending on the oligonucleotide. [6]